展开

碳酸锂

¥ 53.46

产品编号 L101679 | CAS号 554-13-2 | 阿拉丁
Lithium carbonate
AR,≥99.0%
组合的产品项目
货号 规格 库存 价格 数量
L101679-100g AR,≥99.0% 上海(>10)
北方(预计3-5个工作日)
 
L101679-2.5kg AR,≥99.0% 上海(3)
北方(预计3-5个工作日)
 
L101679-25g AR,≥99.0% 上海(预计3-7周)
北方(预计3-7周)
 
L101679-500g AR,≥99.0% 上海(>10)
北方(预计3-5个工作日)
 
客户看了后又看了下面的产品

属性

敏感性 对湿度敏感
密度 2.1100
熔点 723°C
沸点 1230°C
溶解性 Soluble in water (1.33 g in 100 mL at room temperature) and dilute acids. Insoluble in acetone and ethanol.
存贮条件 密封保存。

描述

产品介绍 微溶于水,本品1克能溶于78毫升冷水及140毫升沸水中;溶于稀酸,不溶于醇.
别名 ;Carbonic acid,dilithium salt; Carbolithium Carbonic acid lithium salt
生化机理 Lithium carbonate has been used in psychiatry since the 1950’s to treat mania and depressive disorders. It is an element with a positive charge similar to sodium and potassium. In cells, lithium interferes with other positively charged atoms important to many cellular functions. It interferes with neurotransmitter production and uptake. Current biological studies are looking into lithium treatment for additional CNS disorders such as Alzheimer’s disease.
应用 A lithium preparation used to interfere with neurotransmission
编写您自己的评论
只有注册的用户才可以写评论。请 登录 创建帐户
标识符号 GHS07 GHS07
信号词 Warning
风险声明 (欧洲) R22;R36
安全声明(欧洲) S26;S36/37
警示性声明 P305+P351+P338
危害码(欧洲) Xn
危害声明 H302,H319
个人防护设备 dust mask type N95 (US),Eyeshields,Faceshields,Gloves
RTECS OJ5800000
WGK德国 3
参考文献
R Scott RS Obach, Franco F Lombardo, Nigel J NJ Waters
We present herein a compilation and trend analysis of human i.v. pharmacokinetic data on 670 drugs representing, to our knowledge, the largest publicly available set of human clinical pharmacokinetic ...Read More
Stefan Bittner, Sven G Meuth, Kerstin G?bel, Nico Melzer, Alexander M Herrmann, Ole J Simon, Andreas Weishaupt, Thomas Budde, Douglas A Bayliss, Martin Bendszus, Heinz Wiendl
We provide evidence that TWIK-related acid-sensitive potassium channel 1 (TASK1), a member of the family of two-pore domain potassium channels relevant for setting the resting membrane potential and b...Read More
Ashwati Raghunath
The patient is a 52-year-old man with schizophrenia who developed severe, unremitting gingival pain after his ziprasidone dosage was increased from 80 to 120 mg. His physical examination and laborator...Read More
Carl Redshaw, Oliver Rowe, David L Hughes, Anna-Marie Fuller, Ilich A Ibarra, Simon M Humphrey
The structures of three novel compounds prepared from the reaction of the lower-rim 1,3-diacid calix[4]arene (LH(2)) with lithium carbonate (), t-butyl-lithium () and zinc acetate () are reported....Read More
Saija M Savolainen, Julie F Foley, Susan A Elmore
In humans, congenital heart diseases are common. Since the rapid progression of transgenic technologies, the mouse has become the major animal model of defective cardiovascular development. Moreover, ...Read More
Gabrielle A Carlson
We're sorry this abstract is currently not available....Read More
Joan Prudic, Roger F Haskett, W Vaughn McCall, Keith Isenberg, Thomas Cooper, Peter B Rosenquist, Benoit H Mulsant, Harold A Sackeim
To determine whether starting antidepressant medication at the start of electroconvulsive therapy (ECT) reduces post-ECT relapse and to determine whether continuation pharmacotherapy with nortriptylin...Read More
Andrew A Nierenberg, Edward S Friedman, Charles L Bowden, Louisa G Sylvia, Michael E Thase, Terence Ketter, Michael J Ostacher, Andrew C Leon, Noreen Reilly-Harrington, Dan V Iosifescu, Michael Pencina, Joanne B Severe, Joseph R Calabrese
OBJECTIVE Lithium salts, once the mainstay of therapy for bipolar disorder, have tolerability issues at a higher dosage that often limit adherence. The authors investigated the comparative effectivene...Read More
Tom Bschor, Manfred Uhr, Christopher Baethge, Ute Lewitzka, Marcus Ising, Sebastian Erbe, Patricia Winkelmann, Dirk Ritter
Studies of the 1970s and 1980s showed lithium monotherapy to be an effective treatment of acute unipolar major depressive disorder (MDD) and hence as a potential alternative to monoaminergic antidepre...Read More
Madhulika A Gupta
The self-induced dermatoses (such as trichotillomania, pathologic skin picking or neurotic excoriations, dermatitis artefacta, onychophagia and onychotillomania), which are caused as a result of exces...Read More
Mauricio Tohen
We're sorry this abstract is currently not available....Read More
Gary S Sachs, Douglas G Vanderburg, Suzanne Edman, Onur N Karayal, Sheela Kolluri, Mary Bachinsky, Idil Cavus
High failure rates of randomized controlled trials (RCTs) are well recognized but poorly understood. We report exploratory analyses from an adjunctive ziprasidone double-blind RCT in adults with bipol...Read More
Janusz Rybakowski, Joanna Drogowska, Maria Abramowicz, Maria Ch?opocka-Wo?niak, Stanis?aw Czekalski
In 1963 it was first demonstrated that long-term lithium administration exerts a "mood-stabilising" effect, preventing recurrences of mania and depression in bipolar affective disorder. Desp...Read More
Kamila Krawczyk, Janusz Rybakowski
The aim of this paper was to evaluate the impact of augmenting administered antidepressant treatment of patients suffering from a severe episode of treatment-resistant recurrent depression or bipolar ...Read More
Celen Zerouni, Elaine Kummerow, Mariflor Martinez, Ana Diaz, Uribe Ezequiel, Richard Wix-Ramos
A 40-year-old female patient with bipolar disorder and premenstrual dysphoric disorder did not present any physical evidence of virilization, treated with quetiapine and lithium carbonate. Laboratory ...Read More
A Halboos, F Jockenh?vel
A 69-year-old man came to the emergency unit because of vertigo and presyncope. A bipolar disorder - known since an age of 15 years - has been treated with 2 × 450?mg lithium and 100?mg perazine per ...Read More
Wen-Yu Chen, An-Chin Chen, Shih-Jei Tsai, Juei-Jueng Lin
To report the first case of Taiwanese with lithium intoxication presenting as oro-lingual dyskinesia.A 68-year-old man had bipolar disorder with chronic lithium treatment. He had acute conscious distu...Read More
Lithium has neuroprotective effects in cell and animal models of amyotrophic lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant effect of lithium on survival. W...Read More
Shu-Yu Yang, Ya-Tang Liao, Hsing-Cheng Liu, Wei J Chen, Chiao-Chicy Chen, Chian-Jue Kuo
Like mood stabilizers, most second-generation antipsychotics are widely used to treat patients with bipolar disorder, yet their safety is still a concern. This study explored the association between a...Read More
Boadie W Dunlop, Jeffrey J Rakofsky, Mark Hyman Rapaport
We're sorry this abstract is currently not available....Read More
Andrea Contestabile, Barbara Greco, Diego Ghezzi, Valter Tucci, Fabio Benfenati, Laura Gasparini
Down syndrome (DS) patients exhibit abnormalities of hippocampal-dependent explicit memory, a feature that is replicated in relevant mouse models of the disease. Adult hippocampal neurogenesis, which ...Read More
Neil Cole, Gordon Parker
John Cade's identification of lithium as a treatment of manic-depressive illness has been judged as a landmark biomedical advance and as an initiator of modern psychopharmacology. His personal ba...Read More
Claudia Del Grande, Matteo Muti, Laura Musetti, Irene Pergentini, Martina Corsi, Milo Turri, Ilaria Soldani, Giovanni Umberto Corsini, Liliana Dell'Osso
Despite the great quantity of evidence supporting the efficacy of lithium in the maintenance treatment of bipolar disorder (BD), its use has often been limited because of issues about the management o...Read More
Geraldine S Pearson, Alok Banga
We're sorry this abstract is currently not available....Read More
Mark M Agius, Sophie S Butler
We compare the reported side effects of medication from the trials of prodromal psychosis treatment. We note that the side effects of antipsychotics are those described in the usual pharmacology of th...Read More
Robert L Findling, Vivian Kafantaris, Mani Pavuluri, Nora K McNamara, Jean A Frazier, Linmarie Sikich, Robert Kowatch, Brieana M Rowles, Traci E Clemons, Perdita Taylor-Zapata
Abstract Objective: This study examined the long-term effectiveness of lithium for the treatment of pediatric bipolar disorder within the context of combination mood stabilizer therapy for refractory ...Read More
Danielle S Macêdo, David F de Lucena, Ana Isabelle G Queiroz, Rafaela C Cordeiro, Maíra M Araújo, Francisca Cléa Sousa, Silvania M Vasconcelos, Thomas N Hyphantis, Jo?o Quevedo, Roger S McIntyre, André F Carvalho
Lisdexamfetamine dimesylate (LDX) is a prodrug that requires conversion to d-amphetamine (d-AMPH) for bioactivity. Treatment with d-AMPH induces hyperlocomotion and is regarded as a putative animal mo...Read More